All posts by: Michael Zand

About Michael Zand

Biotech seeking IPO riches limited disclosure of deaths tied to therapy – STAT

Continue reading

2018-03-04 NEWS

STAT

Biotech seeking IPO riches limited disclosure of deaths tied to therapy
STAT
The FDA put Unum’s clinical trial for ACTR087 on hold for two months after two patient deaths caused by the immunotherapy.

and more »

Continue reading

2018-03-04 NEWS

STAT

A biotech seeking IPO riches delayed revealing patient deaths tied to immunotherapy
STAT
rivate biotechs are like Instagram posts. The glossy, successful image they choose to share can hide darker truths. So it’s been with Unum Therapeutics, a buzzy T-cell cancer immunotherapy startup backed by a roster of powerful investors, including the

Continue reading

2018-03-04 NEWS

SelectScience

Here’s Why Crispr Therapeutics AG Jumped Again in February
Motley Fool
Crispr Therapeutics expects to file an application with the FDA later this year that could allow the company to begin human trials before the end of 2018. New drug candidates in pre-clinical development have about a 1% chance of reaching an FDA review
Editorial Article: 7 Steps to Better Gene Editing and CRISPR technology – Special FeatureSelectScience
CRISPR Therapeutics AG (CRSP) EPS Estimated At $-0.71Frisco Fastball
Financial Newsletter – ZacksZacks
Zacks
all 38 news articles »
Continue reading

2018-03-04 NEWS

CRISPR pioneer’s lab develops system to target infections and cancer
BioNews
Researchers have developed a new application for CRISPR, adapting the system to detect viral infections with high accuracy, a new study finds. When CRISPR was coupled with the enzyme Cas12a, researchers at the University of California, Berkeley, found

Continue reading

2018-03-04 NEWS

BioEdge

After 14 years, California’s stem cell agency finally gets a royalty cheque
BioEdge
Fourteen years after Californians voted an overwhelming Yes! to stem cell research, including human embryonic stem cells, and created the California Institute for Regenerative Medicine (CIRM), the agency has received its first royalty cheque. The

Continue reading

2018-03-03 NEWS

The Daily Herald

The jury’s out on stem cell treatments for arthritic pain
The Daily Herald
Last year, the federal Food and Drug Administration said that inflated health promises made by some unscrupulous stem cell clinics are galloping ahead of reality. “A select few, often motivated by greed without regard to responsible patient care, are
Families Hold Out Hope for Advances in Dental Stem Cell TherapyFOX40
Stem cell donor saves sibling’s life in SwedenSaudi Gazette
Henlow fundraiser tells how she donated stem cells to save brother’s lifeComet 24
Lymphoma News Today –Digital Journal –Newburgh Gazette –e-Market Research
all 28 news articles »